Ivermectin in the prevention of covid-19
Phase 3
- Registration Number
- CTRI/2020/06/026232
- Lead Sponsor
- DVFM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects who are not suffering from active illness due to infection at the time of inclusion .
Exclusion Criteria
1.Pregnant and lactating women.
2.Subjects suffering from active illness due to infection at the time of inclusion.
3.Subjects suffering from uncontrolled DM, HTN etc
4.Subjects who are known cases of immune-compromised or autoimmune condition such as HIV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method